150 related articles for article (PubMed ID: 34778362)
1. Potential Value of Matrix Metalloproteinase-13 as a Biomarker for Osteoarthritis.
Xin X; Tan Q; Li F; Chen Z; Zhang K; Li F; Yang B; Xing Z; Zhou F; Tian Y; Lv Y; Zhu T
Front Surg; 2021; 8():750047. PubMed ID: 34778362
[No Abstract] [Full Text] [Related]
2. Serum periostin level is not sufficient to serve as a clinically applicable biomarker of osteoarthritis.
Tan Q; Yang Z; Xin X; Yang B; Xing Z; Li F; Zhang K; Tian Y; Zhu T
BMC Musculoskelet Disord; 2022 Dec; 23(1):1039. PubMed ID: 36451121
[TBL] [Abstract][Full Text] [Related]
3. Associations between serum S100A8/S100A9 and knee symptoms, joint structures and cartilage enzymes in patients with knee osteoarthritis.
Ruan G; Xu J; Wang K; Zheng S; Wu J; Ren J; Bian F; Chang B; Zhu Z; Han W; Ding C
Osteoarthritis Cartilage; 2019 Jan; 27(1):99-105. PubMed ID: 30240939
[TBL] [Abstract][Full Text] [Related]
4. Associations between serum IL-8 and knee symptoms, joint structures, and cartilage or bone biomarkers in patients with knee osteoarthritis.
Ruan G; Xu J; Wang K; Zheng S; Wu J; Bian F; Chang B; Zhang Y; Meng T; Zhu Z; Han W; Ding C
Clin Rheumatol; 2019 Dec; 38(12):3609-3617. PubMed ID: 31377918
[TBL] [Abstract][Full Text] [Related]
5. The Role of Matrix Metalloproteinase 13 and Vitamin D in Osteoarthritis: A Hospital-Based Observational Study.
Kumar P; Kumar S; Abhilasha A; Singh A; Kumar U
Cureus; 2023 Sep; 15(9):e45437. PubMed ID: 37859901
[TBL] [Abstract][Full Text] [Related]
6. Follistatin-like protein 1: a serum biochemical marker reflecting the severity of joint damage in patients with osteoarthritis.
Wang Y; Li D; Xu N; Tao W; Zhu R; Sun R; Fan W; Zhang P; Dong T; Yu L
Arthritis Res Ther; 2011; 13(6):R193. PubMed ID: 22117761
[TBL] [Abstract][Full Text] [Related]
7. Cartilage oligomeric protein, matrix metalloproteinase-3, and Coll2-1 as serum biomarkers in knee osteoarthritis: a cross-sectional study.
Georgiev T; Ivanova M; Kopchev A; Velikova T; Miloshov A; Kurteva E; Yuzeir K; Penkov M; Kabakchieva P; Rashkov R; Stoilov R
Rheumatol Int; 2018 May; 38(5):821-830. PubMed ID: 29164307
[TBL] [Abstract][Full Text] [Related]
8. Synovial fluid alpha-melanocyte-stimulating hormone may act as a protective biomarker for primary knee osteoarthritis.
Guan J; Li Y; Ding LB; Liu GY; Zheng XF; Xue W; Wang HJ
Discov Med; 2019 Jan; 27(146):17-26. PubMed ID: 30721648
[TBL] [Abstract][Full Text] [Related]
9. Associations of serum citrate levels with knee structural changes and cartilage enzymes in patients with knee osteoarthritis.
Bian F; Ruan G; Xu J; Wang K; Wu J; Ren J; Chang B; Ding C
Int J Rheum Dis; 2020 Mar; 23(3):435-442. PubMed ID: 31957331
[TBL] [Abstract][Full Text] [Related]
10. Synovial Fluid Eotaxin-1 Levels May Reflect Disease Progression in Primary Knee Osteoarthritis Among Elderly Han Chinese: A Cross-Sectional Study.
Li B; Zhang YL; Yu SY
Cartilage; 2019 Oct; 10(4):408-416. PubMed ID: 29562767
[TBL] [Abstract][Full Text] [Related]
11. Association of UCMA levels in serum and synovial fluid with severity of knee osteoarthritis.
Okuyan HM; Terzi MY; Ozcan O; Kalaci A
Int J Rheum Dis; 2019 Oct; 22(10):1884-1890. PubMed ID: 31424176
[TBL] [Abstract][Full Text] [Related]
12. Correlation of bone morphogenetic protein-2 levels in serum and synovial fluid with disease severity of knee osteoarthritis.
Liu Y; Hou R; Yin R; Yin W
Med Sci Monit; 2015 Jan; 21():363-70. PubMed ID: 25644704
[TBL] [Abstract][Full Text] [Related]
13. Serum hsa_circ_101178 as a Potential Biomarker for Early Prediction of Osteoarthritis.
Chen C
Clin Lab; 2020 Aug; 66(8):. PubMed ID: 32776746
[TBL] [Abstract][Full Text] [Related]
14. Identification of soluble 14-3-3∊ as a novel subchondral bone mediator involved in cartilage degradation in osteoarthritis.
Priam S; Bougault C; Houard X; Gosset M; Salvat C; Berenbaum F; Jacques C
Arthritis Rheum; 2013 Jul; 65(7):1831-42. PubMed ID: 23552998
[TBL] [Abstract][Full Text] [Related]
15. Decrease of serum biomarker of type II Collagen degradation (Coll2-1) by intra-articular injection of an autologous plasma-rich-platelet in patients with unilateral primary knee osteoarthritis.
Fawzy RM; Hashaad NI; Mansour AI
Eur J Rheumatol; 2017 Jun; 4(2):93-97. PubMed ID: 28638679
[TBL] [Abstract][Full Text] [Related]
16. Associations between serum ghrelin and knee symptoms, joint structures and cartilage or bone biomarkers in patients with knee osteoarthritis.
Wu J; Wang K; Xu J; Ruan G; Zhu Q; Cai J; Ren J; Zheng S; Zhu Z; Otahal P; Ding C
Osteoarthritis Cartilage; 2017 Sep; 25(9):1428-1435. PubMed ID: 28602782
[TBL] [Abstract][Full Text] [Related]
17. Adiponectin: is it a biomarker for assessing the disease severity in knee osteoarthritis patients?
Cuzdan Coskun N; Ay S; Evcik FD; Oztuna D
Int J Rheum Dis; 2017 Dec; 20(12):1942-1949. PubMed ID: 26544540
[TBL] [Abstract][Full Text] [Related]
18. Synovial fluid levels of TWEAK and matrix metalloproteinase 1 in patients with osteoarthritis, and associations with disease severity.
Hwang IY; Youm YS; Cho SD; Choi SW; Bae MH; Park SJ; Kim HW
J Orthop Surg (Hong Kong); 2018; 26(1):2309499018760112. PubMed ID: 29486670
[TBL] [Abstract][Full Text] [Related]
19. Possible Involvement of Serum and Synovial Fluid Resistin in Knee Osteoarthritis: Cartilage Damage, Clinical, and Radiological Links.
Song YZ; Guan J; Wang HJ; Ma W; Li F; Xu F; Ding LB; Xie L; Liu B; Liu K; Lv Z
J Clin Lab Anal; 2016 Sep; 30(5):437-43. PubMed ID: 26494484
[TBL] [Abstract][Full Text] [Related]
20. Synovial Fluid HMGB-1 Levels are Associated with Osteoarthritis Severity.
Ke X; Jin G; Yang Y; Cao X; Fang R; Feng X; Lei B
Clin Lab; 2015; 61(7):809-18. PubMed ID: 26299081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
